ABBV vs MU: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Micron Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
AbbVie Inc. · Healthcare
$208.05
+4.5% upside to fair value
Grade C
High Quality
VS
Micron Technology, Inc. · Technology
$421.51
-20.2% upside to fair value
Low Conviction
Grade D
QuantHub Verdict
ABBV has more upside to fair value
(+4.5%).
ABBV trades at a lower forward P/E
(14.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
MU |
| Current Price |
$208.05 |
$421.51 |
| Fair Value Estimate |
$217.50 |
$336.45 |
| Upside to Fair Value |
+4.5%
|
-20.2%
|
| Market Cap |
$367.9B |
$475.4B |
| Forward P/E |
14.9x
|
19.7x
|
| EV / EBITDA |
16.7x
|
12.8x
|
| Price / Sales |
6.1x
|
8.2x
|
| Price / FCF |
20.9x
|
21.6x
|
| Revenue Growth YoY |
+8.6%
|
+74.9%
|
| Gross Margin |
83.7%
|
58.4%
|
| Operating Margin |
34.7%
|
48.5%
|
| Return on Equity |
-129.24%
|
40.8%
|
| Dividend Yield |
3.2% |
0% |
| FCF Yield |
4.78%
|
4.64%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a leading diversified biopharmaceutical company navigating the post-Humira transition with strong momentum from Skyrizi and Rinvoq in immunology and continued growth in neuroscience. Full-year 2025 revenue reached $61.2 billion with a gross margin of 83.7% and operating margin of 34.7%, demonstrating operational strength despite the ongoing Humira erosion. Management guides to $67 billi…
Micron Technology, Inc. is a leading semiconductor company specializing in memory and storage solutions, including DRAM and NAND products, which are critical for AI, data centers, mobile, and embedded applications. The company benefits from strong revenue growth of 74.9% year-over-year and exceptional profitability with a net margin of 41.5% and return on equity of 40.8%. Despite these strengths …
Accumulation Zones
| Metric |
ABBV |
MU |
| Zone Low |
$163.13 |
$252.34 |
| Zone High |
$184.88 |
$285.98 |
| In Buy Zone? |
No
|
No
|